U.S. researchers concentrating on four possible treatments for long COVID (like that pictured being analyzed at the Walter Reed Army Institute of Research in 2020) are kicking off Phase 2 clinical trials this week. File Photo by Walter Reed Army Institute of Research | License Photo
July 31 (UPI) — Federal health officials on Monday kicked off enrollment for at least four potential treatments for long COVID and said additional trials for at least seven more treatments are coming soon. The new trials are coming as part of the National Institutes of Health’s RECOVER Initiative, a large, nationwide research program designed to understand, treat and prevent long COVID, officials said in a statement. Advertisement
Long COVID is marked by long-term symptoms after infection by SARS-CoV-2, the virus that causes COVID-19. With more than 200 different symptoms reported, however, it has become apparent that a
NIH announces start of Phase 2 clinical trials for 4 long COVID treatments
